000 05713nam a22004455i 4500
001 107847
003 DE-He213
005 20230102113324.0
007 cr nn 008mamaa
008 181112s2018 gw | s |||| 0|eng d
020 _a9783319988542
_9
024 7 _a10.1007/978-3-319-98854-2
_2doi
050 4 _aRC280 2018 EB
040 _aES-MaUEC
_bspa
245 0 0 _aCritical Issues in Head and Neck Oncology :
_bKey Concepts from the Sixth THNO Meeting
_cedited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O'Sullivan.
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2018.
300 _a1 recurso en línea ( IX, 363 páginas 50 ilustraciones, 44 ilustraciones a color)
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
505 0 _aPart I. Epidemiology and diagnosis -- The role of vaccination in head and neck cancer prevention -- Cellular and molecular pathology in head and neck cancer -- Part II. Prediction of outcome -- Oncogenomics/proteomics of head and neck cancer -- Targeted next-generation sequencing in head and neck cancer -- Homologous recombination function as predictor of treatment response -- Part III. Oral cavity cancer -- Surgical management of oral cavity cancer -- Reconstruction in oral cavity cancer: when and how -- Induction chemotherapy: does it have a place in oral cavity cancer? -- Are there alternative local treatments in oral cavity cancer? -- Part IV. Oropharynx cancer -- HPV assessment in oropharynx cancer: what is the gold standard? -- A new staging system for oropharynx cancer and why? -- Should we de-escalate the treatment in HPV-positive oropharynx cancer? -- Is there a new role for surgery in oropharynx cancer? -- Can we expect less toxicity with newer forms of radiation? -- Part V. Miscellaneous topics -- What is the optimal larynx preservation approach and who are the candidates? -- Is the approach to patients with unknown primary tumors any different in 2017? -- Cytotoxic chemotherapy and targeted therapy in nasopharynx cancer -- Are there alternative chemotherapy regimens for EXTREME in recurrent/metastatic SCCHN -- New data on systemic therapy of salivary gland tumors -- Treatment of elderly patients with head and neck cancer -- Part VI. Thyroid cancer -- World-wide thyroid cancer epidemics: what is going on? -- The surgical approach to thyroid cancer in 2017 -- Part VII. Keynote address -- Immunology and immunotherapy in head and neck cancer -- .
520 _aThis book provides an overview of the latest advances in head and neck cancer using a multidisciplinary approach. Commencing with a discussion of epidemiological and diagnostic aspects, including the role of vaccination and key pathological features, the book then follows by examining the role of oncogenomics, proteomics, next generation sequencing and homologous recombination function in predicting outcomes. The topics are presented by epidemiologists, pathologists and basic scientists with further contributions from medical oncologists, head and neck cancer surgical specialists (ORL /HNS), and radiation oncologists in chapters that discuss therapeutic approaches for oral, oropharyngeal and thyroid cancer. Special topics such as the development of novel staging classifications, optimal larynx preservation approaches for laryngeal and hypopharyngeal cancer, surgical reconstruction, new surgical approaches in oropharynx cancer, potential for treatment de-escalation, systemic therapy in nasopharyngeal cancer and salivary gland tumors and treatment approaches for tumors of unknown primary site are discussed in detail. Finally, the role of immunotherapy in the field is highlighted. The chapters are based on the latest data presented at the 6th Trends in Head and Neck Oncology Conference and reflect the most up-to-date information in the field. They are written by many of the most internationally acclaimed authors in the field and are therefore an excellent source for all those interested or actively working in the field of head and neck cancer.
650 7 _aCabeza
_xCáncer
_2embne
_9210886
650 7 _aCuello
_xCáncer
_2embne
_9210887
650 7 _aOncología
_2embne
_9139207
700 1 _aVermorken, Jan B
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_1http://viaf.org/viaf/290514199
700 1 _aBudach, Volker
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_1http://viaf.org/viaf/313405510
700 1 _aLeemans, C. René
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_0http://id.loc.gov/authorities/names/nb2016021833
700 1 _aMachiels, Jean-Pascal
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_1http://viaf.org/viaf/315224459
700 1 _aNicolai, Piero
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_1http://viaf.org/viaf/44587028
700 1 _aO'Sullivan, Brian
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_1http://viaf.org/viaf/26482544
710 2 _aSpringerLink (Online service)
_0http://id.loc.gov/authorities/names/no2005046756
_1http://viaf.org/viaf/148105729
_9106996
776 0 8 _iPrinted edition:
_z9783319988535
776 0 8 _iPrinted edition:
_z9783319988559
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-98854-2
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
490 _aMedicine (Springer-11650)
988 _aSpringer_Medicine_2018
998 _aSI
_a_alco
_a_vill
_b06/2019
_cm
_dz
_ef
_feng
_ggw
_h0
999 _c107847
_d107847
_x1